Vera Therapeutics Announces Late-Breaking Oral Presentation

Vera Therapeutics Announces Late-Breaking Oral Presentation

Two informational posters for ORIGIN Phase 3 and ORIGIN Extend trials of atacicept in IgAN accepted for presentation at Kidney Week...
29 minutes ago
from: GlobeNewswire

Continue reading...
American Society of Nephrology, Atacicept, IgA nephropathy, Nephrology
More about this
- Vera Therapeutics Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases
PIONEER study expands the investigation of atacicept into a broad definition of IgA nephropathy and into multiple autoimmune glomerular...
from: Yahoo Finance
- Vera Therapeutics Announces Late-Breaking Oral Presentation
Two informational posters for ORIGIN Phase 3 and ORIGIN Extend trials of atacicept in IgAN accepted for presentation at Kidney Week...
from: GlobeNewswire
- Vera Therapeutics Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases
PIONEER study expands the investigation of atacicept into a broad definition of IgA nephropathy and into multiple autoimmune glomerular...
from: Yahoo Finance